1. |
Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis[J]. Prog Retin Eye Res, 2015, 48: 82-118. DOI: 10.1016/j.preteyeres.2015.05.003.
|
2. |
赵明威. 努力探索发病机制, 进一步提升治疗水平: 中心性浆液性脉络膜视网膜病变研究的现实与挑战[J]. 中华眼底病杂志, 2011, 27(4): 305-308. DOI: 10.3760/cma.j.issn.1005-1015.2011.04.001.Zhao MW. The pathogenesis and the clinical management: the challenges of treatment of central serous chorioretinopathy faced in reality[J]. Chin J Ocul Fundus Dis, 2011, 27(4): 305-308. DOI: 10.3760/cma.j.issn.1005-1015.2011.04.001.
|
3. |
Gass JD. Pathogenesis of disciform detachment of the neuroepithelium[J]. Am J Ophthalmol, 1967, 63(3): 1-139.
|
4. |
Kim DY, Joe SG, Yang HS, et al. Subfoveal choroidal thickness changes in treated idiopathic central serous chorioretinopathy and their association with recurrence[J]. Retina, 2015, 35(9): 1867-1874. DOI: 10.1097/IAE.0000000000000557.
|
5. |
Hagen S, Ansari-Shahrezaei S, Smretschnig E, et al. The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy[J]. Graefe's Arch Clin Exp Ophthalmol, 2013, 251(4): 1081-1089. DOI: 10.1007/s00417-012-2139-9.
|
6. |
Zhao M, Zhang F, Chen Y, et al. A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial[J]. JAMA Ophthalmol, 2015, 133(3): 333-340. DOI: 10.1001/jamaophthalmol.2014.5312.
|
7. |
Kim KS, Lee WK, Lee SB. Half-dose photodynamic therapy targeting the leakage point on the fluorescein angiography in acute central serous chorioretinopathy: a pilot study[J]. Am J Ophthalmol, 2014, 157(2): 366-373. DOI: 10.1016/j.ajo.2013.10.013.
|
8. |
廖燕红, 周宏建. 半剂量维替泊芬光动力疗法治疗纤维蛋白沉积为主的中心性浆液性脉络膜视网膜病变二例[J]. 中华眼底病杂志, 2011, 27(3): 294-295. DOI: 10.3760/cma.j.issn.1005-1015.2011.03.029.Liao YH, Zhou HJ. Half-dose verteporfin photodynamic therapy for two cases of central serous chorioretinopathy with fibrin deposition[J]. Chin J Ocul Fundus Dis, 2011, 27(3): 294-295. DOI: 10.3760/cma.j.issn.1005-1015.2011.03.029.
|
9. |
李鹏程, 盛双燕, 彭冲, 等. 半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变[J]. 中华眼底病杂志, 2011, 27(4): 327-330. DOI: 10.3760/cma.j.issn.1005-1015.2011.04.006.Li PC, Sheng SY, Peng C, et al. Half-dose photodynamic therapy for chronic central serous chorioretinopathy[J]. Chin J Ocul Fundus Dis, 2011, 27(4): 327-330. DOI: 10.3760/cma.j.issn.1005-1015.2011.04.006.
|
10. |
Razavi S, Souied EH, Cavallero E, et al. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy[J]. Am J Ophthalmol, 2014, 157(4): 852-860. DOI: 10.1016/j.ajo.2013.12.029.
|
11. |
van Rijssen TJ, van Dijk EHC, Yzer S, et al. Central serous chorioretinopathy: towards an evidence-based treatment guideline[J/OL]. Prog Retin Eye Res, 2019, 73: 100770[2019-07-15]. https://pubmed.ncbi.nlm.nih.gov/31319157/. DOI: 10.1016/j.preteyeres.2019.07.003.
|
12. |
Zhao MW, Zhou P, Xiao HX, et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin[J]. Retina, 2009, 29(8): 1155-1161. DOI: 10.1097/IAE.0b013e3181a6c028.
|
13. |
Chan WM, Lai TY, Lai RY, et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial[J]. Ophthalmology, 2008, 115(10): 1756-1765. DOI: 10.1016/j.ophtha.2008.04.014.
|
14. |
Gilbert CM, Owens SL, Smith PD, et al. Long-term follow-up of central serous chorioretinopathy[J]. Br J Ophthalmol, 1984, 68(11): 815-820. DOI: 10.1136/bjo.68.11.815.
|
15. |
Leaver P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy[J]. Br J Ophthalmol, 1979, 63(10): 674-677. DOI: 10.1136/bjo.63.10.674.
|
16. |
毕燕龙, 荣翱, 李锦文. 微脉冲激光治疗中心性浆液性脉络膜视网膜病变的临床疗效[J]. 中华眼底病杂志, 2007, 23(1): 45-47.Bi YL, Rong A, Li JW. Therapeutic effect of micropulse photocoagulation on central serous chorioretinopathy[J]. Chin J Ocul Fundus Dis, 2007, 23(1): 45-47.
|